Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Strati

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|January 12, 2026
Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphomaKunhwa Kim, Rahul Shah, Amy Ayers, et al.
Leukemia & Lymphoma|August 26, 2021
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphomaHua-Jay J Cherng, Hubert H Chuang, Raphael Steiner, et al.
Haematologica|October 12, 2019
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphomaPaolo Strati, Mohamed Amin Ahmed, Nathan H Fowler, et al.
Advances in Radiation Oncology|July 14, 2023
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of LymphomaSusan Y Wu, Penny Q Fang, Ethan B Wang, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
Experimental Hematology & Oncology|March 21, 2023
PD-L1<sup>+</sup> macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphomaRaphael E Steiner, Edwin R Parra, Francisco Vega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2025
A Phase I Trial of Evorpacept, Lenalidomide and Rituximab for Patients with B-cell Non-Hodgkin LymphomaPaolo Strati, Lei Feng, Andrey Tyshevich, et al.
American Journal of Hematology|May 31, 2017
Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemiaElias Jabbour, Naval Guastad Daver, Nicholas James Short, et al.
The Oncologist|August 28, 2020
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium StudyLi Yu, Menghan Shi, Qingqing Cai, et al.
The Journal of Clinical Investigation|July 26, 2022
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responsesGabrielle Romain, Paolo Strati, Ali Rezvan, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|January 12, 2026
Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphomaKunhwa Kim, Rahul Shah, Amy Ayers, et al.
Leukemia & Lymphoma|August 26, 2021
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphomaHua-Jay J Cherng, Hubert H Chuang, Raphael Steiner, et al.
Haematologica|October 12, 2019
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphomaPaolo Strati, Mohamed Amin Ahmed, Nathan H Fowler, et al.
Advances in Radiation Oncology|July 14, 2023
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of LymphomaSusan Y Wu, Penny Q Fang, Ethan B Wang, et al.
The Lancet. Haematology|August 30, 2016
Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trialPaolo Strati, Mark Lanasa, Timothy G Call, et al.
Experimental Hematology & Oncology|March 21, 2023
PD-L1<sup>+</sup> macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphomaRaphael E Steiner, Edwin R Parra, Francisco Vega, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2025
A Phase I Trial of Evorpacept, Lenalidomide and Rituximab for Patients with B-cell Non-Hodgkin LymphomaPaolo Strati, Lei Feng, Andrey Tyshevich, et al.
American Journal of Hematology|May 31, 2017
Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemiaElias Jabbour, Naval Guastad Daver, Nicholas James Short, et al.
The Oncologist|August 28, 2020
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium StudyLi Yu, Menghan Shi, Qingqing Cai, et al.
The Journal of Clinical Investigation|July 26, 2022
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responsesGabrielle Romain, Paolo Strati, Ali Rezvan, et al.
Pageof 14